Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for ANDA 065481

Expand all

CEFTAZIDIME (CEFTAZIDIME)
500MG/VIAL
Marketing Status: Discontinued

Active Ingredient: CEFTAZIDIME
Proprietary Name: CEFTAZIDIME
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 500MG/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A065481
Product Number: 001
Approval Date: May 28, 2010
Applicant Holder Full Name: AUROBINDO PHARMA LTD
Marketing Status:  Discontinued
Patent and Exclusivity Information

CEFTAZIDIME (CEFTAZIDIME)
1GM/VIAL
Marketing Status: Discontinued

Active Ingredient: CEFTAZIDIME
Proprietary Name: CEFTAZIDIME
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 1GM/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A065481
Product Number: 002
Approval Date: May 28, 2010
Applicant Holder Full Name: AUROBINDO PHARMA LTD
Marketing Status:  Discontinued
Patent and Exclusivity Information

CEFTAZIDIME (CEFTAZIDIME)
2GM/VIAL
Marketing Status: Discontinued

Active Ingredient: CEFTAZIDIME
Proprietary Name: CEFTAZIDIME
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 2GM/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A065481
Product Number: 003
Approval Date: May 28, 2010
Applicant Holder Full Name: AUROBINDO PHARMA LTD
Marketing Status:  Discontinued
Patent and Exclusivity Information